Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine supraorbital and infraorbital nerve block for pain after rhinoplasty
IRCT20131020015083N5Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine in postoperative pain (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Amount of nasal pain, Analgesic use and 2 more. Started Feb 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20131020015083N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131020015083N5.